Gujarat Themis Biosyn Schedules Board Meeting on May 25, 2026 to Approve FY26 Audited Results and Consider Dividend
Gujarat Themis Biosyn Limited has scheduled a Board of Directors meeting on May 25, 2026, to approve audited financial results for the quarter and financial year ended March 31, 2026, along with the auditor's reports. The board will also consider recommending a dividend, if any, on equity shares for FY26. In line with SEBI's Prohibition of Insider Trading Regulations, the company's Trading Window has been closed from April 1, 2026, and will remain shut until 48 hours after the publication of the financial results.

*this image is generated using AI for illustrative purposes only.
Gujarat Themis Biosyn Limited has intimated stock exchanges of an upcoming Board of Directors meeting scheduled for Monday, May 25, 2026, in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notice, dated May 19, 2026, was filed by Company Secretary & Compliance Officer Vineet Gawankar on behalf of the company.
Board Meeting Agenda
The board meeting has been convened to transact the following key business items:
| Agenda Item: | Details |
|---|---|
| Financial Results: | Audited financial results for the quarter and financial year ended March 31, 2026, along with auditor's reports |
| Dividend Consideration: | To consider recommending dividend, if any, on equity shares for the financial year ended March 31, 2026 |
Trading Window Closure
In accordance with the company's Code of Conduct for Prevention of Insider Trading, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, Gujarat Themis Biosyn had already notified its Designated Persons regarding the closure of the Trading Window. The Trading Window has remained closed from April 1, 2026 and will continue to remain closed until the expiry of 48 hours from the date of publication of the financial results.
The intimation was addressed to both the Corporate Relationship Department, BSE Limited, and the Listing Department, National Stock Exchange of India Limited, as part of the company's regulatory disclosure obligations.
Historical Stock Returns for Gujarat Themis Biosyn
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.53% | -7.59% | +11.65% | -18.01% | +6.65% | +46.33% |
How does Gujarat Themis Biosyn's expected dividend payout for FY2026 compare to its historical dividend distribution trends, and what does it signal about the company's cash flow position?
Given the trading window closure since April 1, 2026, how might the release of FY2026 audited results impact institutional investor sentiment and trading volumes in the stock?
What are the key financial performance metrics analysts are watching for Gujarat Themis Biosyn's FY2026 results, particularly in the context of the broader biosynthetics and pharmaceutical sector?


































